z-logo
open-access-imgOpen Access
Apelin-13: A promising biomarker for multiple sclerosis?
Author(s) -
Murat Alpua,
Yakup Türkel,
Ersel Dağ,
Üçler Kısa
Publication year - 2018
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/aian.aian_377_17
Subject(s) - apelin , medicine , multiple sclerosis , biomarker , expanded disability status scale , disease , gastroenterology , oncology , immunology , receptor , biochemistry , chemistry
Recent studies have shown that Apelin 13 may have a neuroprotective property. Therefore it can be used as a biomarker for multiple sclerosis. Our purpose to assess serum apelin-13 levels in adult patients with multiple sclerosis and healthy controls.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here